Nutraceutical Excipients Market (By Functionality: Binder, Disintegrants, Fillers & Diluents, Coating Agent, Flavoring Agent, Lubricants, Others; By Product: Prebiotics, Probiotics, Proteins & Amino Acids; By Type: Artificial, Natural/Organic; By Form: Dry, Liquid; By End Use) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023-2033
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Nutraceutical Excipients Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Nutraceutical Excipients Market, by Functionality, 2024-2033
8.1.1. Binder
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Disintegrants
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. Fillers & Diluents
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Coating Agent
8.1.4.1. Market Revenue and Forecast (2021-2033)
8.1.5. Flavoring Agent
8.1.5.1. Market Revenue and Forecast (2021-2033)
8.1.6. Lubricants
8.1.6.1. Market Revenue and Forecast (2021-2033)
8.1.7. Others
8.1.7.1. Market Revenue and Forecast (2021-2033)
9.1. Nutraceutical Excipients Market, by Product, 2024-2033
9.1.1. Prebiotics
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Probiotics
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Proteins & Amino Acids
9.1.3.1. Market Revenue and Forecast (2021-2033)
10.1. Nutraceutical Excipients Market, by Type, 2024-2033
10.1.1. Artificial
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Natural/Organic
10.1.2.1. Market Revenue and Forecast (2021-2033)
11.1. Nutraceutical Excipients Market, by Form, 2024-2033
11.1.1. Dry
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Liquid
11.1.2.1. Market Revenue and Forecast (2021-2033)
12.1. Nutraceutical Excipients Market, by End Use, 2024-2033
12.1.1. Protein and Amino Acids
12.1.1.1. Market Revenue and Forecast (2021-2033)
12.1.2. Omega 3 Fatty Acids
12.1.2.1. Market Revenue and Forecast (2021-2033)
12.1.3. Vitamins
12.1.3.1. Market Revenue and Forecast (2021-2033)
12.1.4. Minerals
12.1.4.1. Market Revenue and Forecast (2021-2033)
12.1.5. Prebiotics and Probiotics
12.1.5.1. Market Revenue and Forecast (2021-2033)
12.1.6. Others
12.1.6.1. Market Revenue and Forecast (2021-2033)
13.1. North America
13.1.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.1.2. Market Revenue and Forecast, by Product (2021-2033)
13.1.3. Market Revenue and Forecast, by Type (2021-2033)
13.1.4. Market Revenue and Forecast, by Form (2021-2033)
13.1.5. Market Revenue and Forecast, by End Use (2021-2033)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.1.6.2. Market Revenue and Forecast, by Product (2021-2033)
13.1.6.3. Market Revenue and Forecast, by Type (2021-2033)
13.1.6.4. Market Revenue and Forecast, by Form (2021-2033)
13.1.7. Market Revenue and Forecast, by End Use (2021-2033)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.1.8.2. Market Revenue and Forecast, by Product (2021-2033)
13.1.8.3. Market Revenue and Forecast, by Type (2021-2033)
13.1.8.4. Market Revenue and Forecast, by Form (2021-2033)
13.1.8.5. Market Revenue and Forecast, by End Use (2021-2033)
13.2. Europe
13.2.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.2.2. Market Revenue and Forecast, by Product (2021-2033)
13.2.3. Market Revenue and Forecast, by Type (2021-2033)
13.2.4. Market Revenue and Forecast, by Form (2021-2033)
13.2.5. Market Revenue and Forecast, by End Use (2021-2033)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.2.6.2. Market Revenue and Forecast, by Product (2021-2033)
13.2.6.3. Market Revenue and Forecast, by Type (2021-2033)
13.2.7. Market Revenue and Forecast, by Form (2021-2033)
13.2.8. Market Revenue and Forecast, by End Use (2021-2033)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.2.9.2. Market Revenue and Forecast, by Product (2021-2033)
13.2.9.3. Market Revenue and Forecast, by Type (2021-2033)
13.2.10. Market Revenue and Forecast, by Form (2021-2033)
13.2.11. Market Revenue and Forecast, by End Use (2021-2033)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.2.12.2. Market Revenue and Forecast, by Product (2021-2033)
13.2.12.3. Market Revenue and Forecast, by Type (2021-2033)
13.2.12.4. Market Revenue and Forecast, by Form (2021-2033)
13.2.13. Market Revenue and Forecast, by End Use (2021-2033)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.2.14.2. Market Revenue and Forecast, by Product (2021-2033)
13.2.14.3. Market Revenue and Forecast, by Type (2021-2033)
13.2.14.4. Market Revenue and Forecast, by Form (2021-2033)
13.2.15. Market Revenue and Forecast, by End Use (2021-2033)
13.3. APAC
13.3.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.3.2. Market Revenue and Forecast, by Product (2021-2033)
13.3.3. Market Revenue and Forecast, by Type (2021-2033)
13.3.4. Market Revenue and Forecast, by Form (2021-2033)
13.3.5. Market Revenue and Forecast, by End Use (2021-2033)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.3.6.2. Market Revenue and Forecast, by Product (2021-2033)
13.3.6.3. Market Revenue and Forecast, by Type (2021-2033)
13.3.6.4. Market Revenue and Forecast, by Form (2021-2033)
13.3.7. Market Revenue and Forecast, by End Use (2021-2033)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.3.8.2. Market Revenue and Forecast, by Product (2021-2033)
13.3.8.3. Market Revenue and Forecast, by Type (2021-2033)
13.3.8.4. Market Revenue and Forecast, by Form (2021-2033)
13.3.9. Market Revenue and Forecast, by End Use (2021-2033)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.3.10.2. Market Revenue and Forecast, by Product (2021-2033)
13.3.10.3. Market Revenue and Forecast, by Type (2021-2033)
13.3.10.4. Market Revenue and Forecast, by Form (2021-2033)
13.3.10.5. Market Revenue and Forecast, by End Use (2021-2033)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.3.11.2. Market Revenue and Forecast, by Product (2021-2033)
13.3.11.3. Market Revenue and Forecast, by Type (2021-2033)
13.3.11.4. Market Revenue and Forecast, by Form (2021-2033)
13.3.11.5. Market Revenue and Forecast, by End Use (2021-2033)
13.4. MEA
13.4.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.4.2. Market Revenue and Forecast, by Product (2021-2033)
13.4.3. Market Revenue and Forecast, by Type (2021-2033)
13.4.4. Market Revenue and Forecast, by Form (2021-2033)
13.4.5. Market Revenue and Forecast, by End Use (2021-2033)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.4.6.2. Market Revenue and Forecast, by Product (2021-2033)
13.4.6.3. Market Revenue and Forecast, by Type (2021-2033)
13.4.6.4. Market Revenue and Forecast, by Form (2021-2033)
13.4.7. Market Revenue and Forecast, by End Use (2021-2033)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.4.8.2. Market Revenue and Forecast, by Product (2021-2033)
13.4.8.3. Market Revenue and Forecast, by Type (2021-2033)
13.4.8.4. Market Revenue and Forecast, by Form (2021-2033)
13.4.9. Market Revenue and Forecast, by End Use (2021-2033)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.4.10.2. Market Revenue and Forecast, by Product (2021-2033)
13.4.10.3. Market Revenue and Forecast, by Type (2021-2033)
13.4.10.4. Market Revenue and Forecast, by Form (2021-2033)
13.4.10.5. Market Revenue and Forecast, by End Use (2021-2033)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.4.11.2. Market Revenue and Forecast, by Product (2021-2033)
13.4.11.3. Market Revenue and Forecast, by Type (2021-2033)
13.4.11.4. Market Revenue and Forecast, by Form (2021-2033)
13.4.11.5. Market Revenue and Forecast, by End Use (2021-2033)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.5.2. Market Revenue and Forecast, by Product (2021-2033)
13.5.3. Market Revenue and Forecast, by Type (2021-2033)
13.5.4. Market Revenue and Forecast, by Form (2021-2033)
13.5.5. Market Revenue and Forecast, by End Use (2021-2033)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.5.6.2. Market Revenue and Forecast, by Product (2021-2033)
13.5.6.3. Market Revenue and Forecast, by Type (2021-2033)
13.5.6.4. Market Revenue and Forecast, by Form (2021-2033)
13.5.7. Market Revenue and Forecast, by End Use (2021-2033)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Functionality (2021-2033)
13.5.8.2. Market Revenue and Forecast, by Product (2021-2033)
13.5.8.3. Market Revenue and Forecast, by Type (2021-2033)
13.5.8.4. Market Revenue and Forecast, by Form (2021-2033)
13.5.8.5. Market Revenue and Forecast, by End Use (2021-2033)
14.1. DuPont14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. BASF SE
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Cargill Inc
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Shin-Etsu Chemical Co Ltd
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Associated British Foods
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Roquette Freres
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Meggle Group Wasser
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Kerry Group PLC
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Fuji Chemical Industries Co Ltd
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. PharmatransSanaq AG
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client